Quarterly ResultMay 7, 2026, 08:17 AM
Turning Point Brands Q1 Net Sales +16.8% to $124.3M; Modern Oral +133%
AI Summary
Turning Point Brands reported strong first-quarter 2026 financial results, with total consolidated net sales increasing 16.8% to $124.3 million. This growth was primarily driven by a 133% surge in Modern Oral net sales, reaching $52.0 million and accounting for 42% of total company net sales. Despite the sales growth, net income decreased by 19.0% to $11.7 million, and Adjusted EBITDA fell by 6.5% to $25.9 million, impacted by increased sales and marketing investments. The company raised its full-year 2026 Modern Oral sales guidance and introduced full-year Adjusted EBITDA guidance.
Key Highlights
- Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million.
- Total Consolidated Net Sales increased 16.8% to $124.3 million.
- Net Income decreased 19.0% to $11.7 million.
- Adjusted EBITDA decreased 6.5% to $25.9 million.
- Diluted EPS was $0.60, down from $0.79 in Q1 2025.
- Raised FY 2026 Modern Oral Net Sales guidance to $210-$225 million.
- Introduced FY 2026 Adjusted EBITDA guidance of $70-$90 million.
- Stoker's segment net sales increased 48.1% to $87.6 million.